Recurrent Gastrointestinal Stromal Tumors in the Imatinib Mesylate Era: Treatment Strategies for an Incurable Disease

Recurrent Gastrointestinal Stromal Tumors in the Imatinib Mesylate Era: Treatment Strategies for an Incurable Disease

Introduction. Recurrence of gastrointestinal stromal tumors (GISTs) after surgical resection and imatinib mesylate (IM) adjuvant therapy poses a significant treatment challenge. We present the case of a patient who underwent surgical resection after recurrence and review the current literature regar...

Full description

Saved in:
Bibliographic Details
Main Authors: Rebecca M. Platoff, William F. Morano, Luiz Marconcini, Nicholas DeLeo, Beth L. Mapow, Michael Styler, Wilbur B. Bowne
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Case Reports in Oncological Medicine
Online Access:http://dx.doi.org/10.1155/2017/8349090
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items